
    
      Prospective cohort study to assess safety of one dose of theButantan Influenza vaccine
      (Fragmented and Inactivated) in the first 3 days after vaccination and its immunogenicity 21
      days after vaccination among healthy adults with 18 to 59 years of age and elderly older than
      60 years of age..
    
  